Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma

Journal: Nature Communications

Published: 2018-11-07

DOI: 10.1038/s41467-018-06889-5

Affiliations: 23

Authors: 35

Go to article
Institutions FC
School of Biomedical Sciences, HKU, China 0.28
Department of Clinical Oncology, HKU, China 0.16
Department of Anatomical and Cellular Pathology, CUHK, China 0.08
State Key Laboratory of Translational Oncology, CUHK, China 0.08
Department of Paediatrics and Adolescent Medicine, HKU, China 0.06
Department of Computer Science and Engineering (CSE), CUHK, China 0.06
Signalisation, Noyaux et Innovations en Cancérologie, France 0.03
Centre for Genomic Sciences, HKU, China 0.03
Department of Microbiology, HKU, China 0.03
Department of Pathology, HKU, China 0.03
Department of Surgery, HKU, China 0.03
School of Nursing, HKU, China 0.01
Stanford Center for Biomedical Informatics Research (BMIR), United States of America (USA) 0.01
Li Ka Shing Faculty of Medicine, HKU, China 0.01
Department of Surgery, CUHK, China 0.01
Li Ka Shing Institute of Health Sciences, CUHK, China 0.01
College of Life Science and Technology, JNU, China 0.01
Department of Pathology, VU University Amsterdam, Netherlands 0.01
VUmc Cancer Center Amsterdam (CCA), Netherlands 0.01
Department of Pathology, Georgetown University, United States of America (USA) 0.01
Second Xiangya Hospital, CSU, China 0.01
Affiliated Cancer Hospital of Guangzhou Medical University, China 0.01
Center for Cell Reprogramming (CCR), Georgetown University, United States of America (USA) 0.01